Doximity Unveils AI Upgrades and Reports Surge in Scribe Adoption
Reuters
Nov 07, 2025
Doximity Unveils AI Upgrades and Reports Surge in Scribe Adoption
Doximity Inc.'s management recently addressed investors, highlighting advancements in their AI-powered medical tools, including the DoxGPT reference platform and the Doximity Scribe, a HIPAA-compliant ambient note-taking tool. The company reported a significant increase in quarterly active users for Scribe and integrated the tool with their telehealth platform, Doximity Dialer, streamlining the documentation process for clinicians. Management emphasized their commitment to reducing administrative burdens for healthcare professionals and discussed the long-term growth potential of their AI suite. The full remarks and related financial information are available on the company's investor relations website at investors.doximity.com.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Doximity Inc. published the original content used to generate this news brief on November 06, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.